These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6454333)
1. Normal and malignant T cells in the regulation of inflammation and immunity. Broder S Agents Actions Suppl; 1980; 7():134-42. PubMed ID: 6454333 [TBL] [Abstract][Full Text] [Related]
2. Neoplasms of immunoregulatory cells. Broder S; Uchiyama T; Waldmann TA Am J Clin Pathol; 1979 Oct; 72(4 Suppl):724-31. PubMed ID: 158979 [TBL] [Abstract][Full Text] [Related]
3. Neoplasms of immunoregulatory T cells in clinical investigation. Broder S; Muul L; Marshall S; Waldmann TA J Invest Dermatol; 1980 May; 74(5):267-71. PubMed ID: 6967093 [TBL] [Abstract][Full Text] [Related]
4. Current concepts in immunoregulatory T-cell neoplasms. Broder S; Uchiyama T; Waldmann TA Cancer Treat Rep; 1979 Apr; 63(4):607-12. PubMed ID: 312696 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the humoral immune response: from immunoglobulin genes to regulatory T cell networks. Waldmann TA; Korsmeyer SJ; Hieter PA; Ravetch JV; Broder S; Leder P Fed Proc; 1983 May; 42(8):2498-503. PubMed ID: 6404657 [TBL] [Abstract][Full Text] [Related]
6. Abnormalities of immunoregulatory cells in immunodeficiency disease and cancer. Broder S; Muul L; Megson M; Waldmann TA Prog Clin Biol Res; 1981; 58():93-120. PubMed ID: 6455670 [No Abstract] [Full Text] [Related]
8. T cells in cutaneous lesions of Sézary syndrome and T-cell leukemia. Characterization by monoclonal antibodies. Buechner SA; Winkelmann RK; Banks PM Arch Dermatol; 1983 Nov; 119(11):895-900. PubMed ID: 6227293 [TBL] [Abstract][Full Text] [Related]
9. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas. Kamoun M; Kadin ME; Martin PJ; Nettleton J; Hansen JA J Immunol; 1981 Sep; 127(3):987-91. PubMed ID: 6790625 [TBL] [Abstract][Full Text] [Related]
10. Activation of leukemic pro-suppressor cells to become suppressor-effector cells. Influence of cooperating normal T cells. Broder S; Uchiyama T; Muul LM; Goldman C; Sharrow S; Poplack DG; Waldmann TA N Engl J Med; 1981 Jun; 304(23):1382-7. PubMed ID: 6453293 [TBL] [Abstract][Full Text] [Related]
11. [Immunologic phenotyping of cutaneous lymphomas]. Kaudewitz P; Burg G; Smolle J; Braun-Falco O Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828 [TBL] [Abstract][Full Text] [Related]
12. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206 [TBL] [Abstract][Full Text] [Related]
13. Recent advances in the cutaneous T cell lymphomas. Edelson RL Bull Cancer; 1977; 64(2):209-24. PubMed ID: 303131 [TBL] [Abstract][Full Text] [Related]
15. Results of multiparameter studies of T-cell lymphoid neoplasms. Collins RD; Waldron JA; Glick AD Am J Clin Pathol; 1979 Oct; 72(4 Suppl):699-707. PubMed ID: 386780 [TBL] [Abstract][Full Text] [Related]
16. [Membrane markers of lymphoid cells in immunoproliferative diseases of man]. Seligmann M; Brouet JC; Preud'homme JL Z Gesamte Inn Med; 1980 Jan; 35(2):66-9. PubMed ID: 6996351 [TBL] [Abstract][Full Text] [Related]
17. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells. Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648 [TBL] [Abstract][Full Text] [Related]
19. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions. Schmitt D; Thivolet J J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276 [TBL] [Abstract][Full Text] [Related]